Onthophagus taurus Increases Soil Microbes Associated with Nutrient Cycling in California Pastureland Soils von Lipton, Suzanne, Meyer, Rachel S., Richardson, Greg, Philpott, Stacy M.

Volltext

Decrypting bacterial polyphenol metabolism in an anoxic wetland soil von McGivern, Bridget B., Tfaily, Malak M., Borton, Mikayla A., Kosina, Suzanne M., Daly, Rebecca A., Nicora, Carrie D., Purvine, Samuel O., Wong, Allison R., Lipton, Mary S., Hoyt, David W., Northen, Trent R., Hagerman, Ann E., Wrighton, Kelly C.

Volltext

Prevalence and characteristics of allodynia in headache sufferers : A population study von BIGAL, M. E, ASHINA, S, BURSTEIN, R, REED, M. L, BUSE, D, SERRANO, D, LIPTON, R. B

Volltext

Cumulative Lifetime Migraine Incidence in Women and Men von Stewart, WF, Wood, C, Reed, ML, Roy, J, Lipton, RB

Volltext

Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia von DONG HWAN KIM, SRIHARSHA, Lakshmi, WEI XU, KAMEL-REID, Suzanne, XIANGDONG LIU, SIMINOVITCH, Katherine, MESSNER, Hans A, LIPTON, Jeffrey H

Volltext

Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia von Kim, Dong Hwan, Kamel-Reid, Suzanne, Chang, Hong, Sutherland, Robert, Jung, Chul Won, Kim, Hyeoung-Joon, Lee, Je-Jung, Lipton, Jeffrey H

Volltext

Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation... von Kim, Dennis D. H., Novitzky‐Basso, Igor, Kim, Taehyung S., Atenafu, Eshetu G., Forrest, Donna, Savoie, Lynn, Bence‐Bruckler, Isabelle, Keating, Mary‐Margaret, Busque, Lambert, Delage, Robert, Xenocostas, Anargyros, Liew, Elena, Paulson, Kristjan, Stockley, Tracy, Laneuville, Pierre, Lipton, Jeffrey H., Kamel‐Reid, Suzanne, Leber, Brian

Volltext

A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia von Radich, Jerald P., Kopecky, Kenneth J., Appelbaum, Frederick R., Kamel-Reid, Suzanne, Stock, Wendy, Malnassy, Greg, Paietta, Elisabeth, Wadleigh, Martha, Larson, Richard A., Emanuel, Peter, Tallman, Martin, Lipton, Jeff, Turner, A. Robert, Deininger, Michael, Druker, Brian J.

Volltext

BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase von Kim, Dennis Dong Hwan, Kim, Taehyung Simon, Atenafu, Eshetu G., Novitzky Basso, Igor, Forrest, Donna, Bence‐Bruckler, Isabelle, Savoie, Lynn, Busque, Lambert, Keating, Mary‐Margaret, Delage, Robert, Xenocostas, Anargyros, Liew, Elena, Paulson, Kristjan, Stockley, Tracy, Laneuville, Pierre, Lipton, Jeffrey H., Kamel‐Reid, Suzanne, Leber, Brian

Volltext

Effect of preventive treatment with atogepant on quality of life, daily functioning, and headache impact across the spectrum of migraine: Findings from three double-blind, randomiz... von Gottschalk, Christopher, Gandhi, Pranav, Pozo-Rosich, Patricia, Christie, Suzanne, Tassorelli, Cristina, Stokes, Jonathan, Liu, Yingyi, Luo, Lei, Nagy, Krisztian, Trugman, Joel M., Lipton, Richard B.

Volltext

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies von Sanchez, Gina A Montealegre, Reinhardt, Adam, Ramsey, Suzanne, Wittkowski, Helmut, Hashkes, Philip J, Berkun, Yackov, Schalm, Susanne, Murias, Sara, Dare, Jason A, Brown, Diane, Stone, Deborah L, Gao, Ling, Klausmeier, Thomas, Foell, Dirk, de Jesus, Adriana A, Chapelle, Dawn C, Kim, Hanna, Dill, Samantha, Colbert, Robert A, Failla, Laura, Kost, Bahar, O'Brien, Michelle, Reynolds, James C, Folio, Les R, Calvo, Katherine R, Paul, Scott M, Weir, Nargues, Brofferio, Alessandra, Soldatos, Ariane, Biancotto, Angelique, Cowen, Edward W, Digiovanna, John J, Gadina, Massimo, Lipton, Andrew J, Hadigan, Colleen, Holland, Steven M, Fontana, Joseph, Alawad, Ahmad S, Brown, Rebecca J, Rother, Kristina I, Heller, Theo, Brooks, Kristina M, Kumar, Parag, Brooks, Stephen R, Waldman, Meryl, Singh, Harsharan K, Nickeleit, Volker, Silk, Maria, Prakash, Apurva, Janes, Jonathan M, Ozen, Seza, Wakim, Paul G, Brogan, Paul A, Macias, William L, Goldbach-Mansky, Raphaela

Volltext

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts an... von Hughes, Timothy, Deininger, Michael, Hochhaus, Andreas, Branford, Susan, Radich, Jerald, Kaeda, Jaspal, Baccarani, Michele, Cortes, Jorge, Cross, Nicholas C.P., Druker, Brian J., Gabert, Jean, Grimwade, David, Hehlmann, Rüdiger, Kamel-Reid, Suzanne, Lipton, Jeffrey H., Longtine, Janina, Martinelli, Giovanni, Saglio, Giuseppe, Soverini, Simona, Stock, Wendy, Goldman, John M.

Volltext

Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase... von Deininger, Michael W., Kopecky, Kenneth J., Radich, Jerald P., Kamel‐Reid, Suzanne, Stock, Wendy, Paietta, Elisabeth, Emanuel, Peter D., Tallman, Martin, Wadleigh, Martha, Larson, Richard A., Lipton, Jeffrey H., Slovak, Marilyn L., Appelbaum, Frederick R., Druker, Brian J.

Volltext

BCR/ABL level at 6 months identifies good risk CML subgroup after failing early molecular response at 3 months following imatinib therapy for CML in chronic phase von Kim, Dennis (Dong Hwan), Hamad, Nada, Lee, Hong Gi, Kamel‐Reid, Suzanne, Lipton, Jeffrey H.

Volltext

Evaluation for Bleeding Disorders in Suspected Child Abuse von Anderst, James, Carpenter, Shannon L., Abshire, Thomas C., Killough, Emily, Mendonca, Eneida A., Downs, Stephen M., Wetmore, Cynthia, Allen, Carl, Dickens, David, Harper, James, Rogers, Zora R., Jain, Juhi, Warwick, Anne, Yates, Amber, Hord, Jeffrey, Lipton, Jeffrey, Wilson, Hope, Kirkwood, Suzanne, Haney, Suzanne B., Asnes, Andrea Gottsegen, Gavril, Amy R., Girardet, Rebecca Greenlee, Heavilin, Nancy, Gilmartin, Amanda Bird Hoffert, Laskey, Antoinette, Messner, Stephen A., Mohr, Bethany Anne, Nienow, Shalon Marie, Rosado, Norell, Idzerda, Sheila M., Legano, Lori A., Raj, Anish, Sirotnak, Andrew P., Forkey, Heather C., Keeshin, Brooks, Matjasko, Jennifer, Edward, Heather, Chavdar, Müge, Di Paola, Jorge, Leavey, Patrick, Graham, Doug, Hastings, Caroline, Hijiya, Nobuko, Matthews, Dana, Pace, Betty, Velez, Maria C., Wechsler, Dan, Billett, Amy, Stork, Linda, Hooker, Ryan

Volltext

Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen von Storring, John M., Minden, Mark D., Kao, Susan, Gupta, Vikas, Schuh, Andre C., Schimmer, Aaron D., Yee, Karen W. L., Kamel‐Reid, Suzanne, Chang, Hong, Lipton, Jeffrey H., Messner, Hans A., Xu, Wei, Brandwein, Joseph M.

Volltext

Unique Lipoprotein Phenotype and Genotype Associated With Exceptional Longevity von Barzilai, Nir, Atzmon, Gil, Schechter, Clyde, Schaefer, Ernst J, Cupples, Adrienne L, Lipton, Richard, Cheng, Suzanne, Shuldiner, Alan R

Volltext

Optimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAFV600E mutation von Tie, Jeanne, Gibbs, Peter, Lipton, Lara, Christie, Michael, Jorissen, Robert N., Burgess, Antony W., Croxford, Matthew, Jones, Ian, Langland, Rachel, Kosmider, Suzanne, McKay, Daniel, Bollag, Gideon, Nolop, Keith, Sieber, Oliver M., Desai, Jayesh

Volltext

Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation von Tie, Jeanne, Gibbs, Peter, Lipton, Lara, Christie, Michael, Jorissen, Robert N, Burgess, Antony W, Croxford, Matthew, Jones, Ian, Langland, Rachel, Kosmider, Suzanne, McKay, Daniel, Bollag, Gideon, Nolop, Keith, Sieber, Oliver M, Desai, Jayesh

Volltext

Adjuvant therapies for colorectal cancer von Kosmider, Suzanne, Lipton, Lara

Volltext